Results 151 to 160 of about 70,663 (209)

Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis. [PDF]

Cardiooncology
Maleki S, Esmaeili Z, Seighali N, Shafiee A, Namin SM, Zavareh MAT, Khamene SS, Mohammadkhawajah I, Nanna M, Alizadeh-Asl A, M Kwan J, Hosseini K.   +11 more
europepmc   +1 more source

Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies. [PDF]

Chin Med J (Engl)
Tu S, Luo X, Mei H, Hu Y, Liu Y, Li P, Zou D, Niu T, Xu K, Zhang X, Qiu L, Gao L, Gao G, Zhang L, Feng Y, Wang Y, Zhao M, Mi J, Hou M, Yang J, Huang H, Wang J, Hu Y, Zhao W, Wu D, Ma J, Li Y, Qian W, Huang X, Han W, Liang A.   +30 more
europepmc   +1 more source

Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct. [PDF]

PLoS One
Zenere G, Wu C, Midkiff CC, Johnson NM, Grice CP, Wimley WC, Kaur A, Braun SE.   +7 more
europepmc   +1 more source

CD28 hinge used in chimeric antigen receptor (CAR) T-cells exhibits local structure and conformational exchange amidst global disorder. [PDF]

Commun Biol
Folimonova V, Chen X, Negi H, Schwieters CD, Li J, Byrd RA, Taylor N, Youkharibache P, Walters KJ.   +8 more
europepmc   +1 more source

Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells. [PDF]

Cancer Immunol Immunother
Kline K, Luetkens T, Koka R, Kallen ME, Chen W, Ahmad H, Omili D, Iraguha T, Gebru E, Fan X, Miller A, Dishanthan N, Baker JM, Dietze KA, Hankey KG, Yared JA, Hardy NM, Rapoport AP, Dahiya S, Atanackovic D.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma

NeuroMolecular Medicine, 2021
Glioblastoma (GBM) are the most common and aggressive primary brain tumors in adults. Current mainstay treatments include surgery, chemotherapy, and radiation; however, these are ineffective. As a result, immunotherapy treatment strategies are being developed to harness the body's natural defense mechanisms against gliomas.
Lisa Feldman, Christine Brown, Behnam Badie   +2 more
openaire   +2 more sources